Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The sphingomyelin pathway, initiated by hydrolysis of sphingomyelin to ceramide and stimulation of a Ser/Thr ceramide-activated protein (CAP) kinase, mediates tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta action. CAP kinase is membrane-bound and proline-directed, recognizing the minimal substrate motif Thr-Leu-Pro.
TNF
may use the sphingomyelin pathway to signal Raf1 to activate the
MAP kinase
cascade. Evidence shows that cytoplasmic Raf1 binds to GTP-ras upon cellular stimulation, is recruited to the plasma membrane, and activated. How membrane-bound Raf1 is activated is uncertain, but regulation of its kinase activity may involve its phosphorylation. Specific Raf kinases, however, have not hitherto been identified. Here we report that CAP kinase phosphorylates Raf1 on Thr 269, increasing its activity towards MEK (MAP kinase or ERK kinase). Moreover, in intact HL-60 cells, CAP kinase complexes with Raf1 and, in response to
TNF
and ceramide analogues, phosphorylates and activates Raf1, implicating CAP kinase as a link between the TNF receptor and Raf1.
...
PMID:Phosphorylation of Raf by ceramide-activated protein kinase. 747 54
The pleiotropic cytokine tumor necrosis factor-alpha (
TNF
alpha) controls the expression of multiple gene products in macrophages and plays an important role in host defense.
TNF
alpha is recognized by the receptors, CD120a (p55) and CD120b (p75). Ligation of CD120a (p55) by
TNF
alpha or by anti-receptor agonistic antibodies initiates signal transduction leading to the activation of mitogen-activated protein kinases (MAPKs) (
p42mapk
/erk2 and p44mapk/erk1). Phosphorylation and activation of
MAPK
are mediated by
MAPK
kinase (MEK), a family of Thr/Tyr kinases. In this study, we investigated the preferential involvement of the MEK isoforms MEK1 and MEK2 in the activation of
p42mapk
/erk2 in mouse macrophages stimulated with
TNF
alpha. Exposure of macrophages to
TNF
alpha stimulated a time-dependent increase in the activity of MEK1 as measured by an in vitro kinase assay using kinase-inactive
p42mapk
/erk2 (rMAPKkd) as substrate in the presence of gamma-[32P]ATP. Maximal activation of MEK1 was detected at 10 min poststimulation and coincided with maximal transphosphorylation of Tyr and Thr residues of rMAPKkd. By contrast, there was no evidence of MEK2 activation in macrophages in response to
TNF
alpha. These data suggest that MEK1 is the preferred substrate for MEK kinase, the upstream kinase implicated in activation of the
MAPK
pathway in macrophages by
TNF
alpha.
...
PMID:Preferential involvement of MEK1 in the tumor necrosis factor-alpha-induced activation of p42mapk/erk2 in mouse macrophages. 749 90
Tumor necrosis factor alpha (
TNF
alpha) activates the stress-activated protein kinases (SAPKs, also known as Jun nuclear kinases or JNKs) resulting in the stimulation of AP-1-dependent gene transcription and induces the translocation of NF kappa B to the nucleus resulting in the stimulation of NF kappa B-dependent gene transcription. A potential second messenger for these signaling pathways is ceramide, which is generated when
TNF
alpha activates sphingomyelinases. We show that treatment of HL-60 human promyelocytic cells with exogenous sphingomyelinase leads to rapid stimulation of
JNK
/
SAPK
activity, an effect not mimicked by treatment with phospholipase A2, C, or D. Further,
JNK
/
SAPK
activity is stimulated 2.7- and 2.8-fold, respectively, in cells exposed to C2-ceramide (5 microM) or
TNF
alpha (10 ng/ml). The prolonged stimulation of this kinase activity by C2-ceramide is similar to that previously reported for
TNF
alpha. In contrast, the related mitogen-activated protein kinases
ERK1
and
ERK2
are weakly stimulated following
TNF
alpha treatment (1.5-fold) and are inhibited by C2-ceramide treatment.
TNF
alpha also potently stimulates NF-kappa B DNA binding activity and transcriptional activity, but these effects are not mimicked by addition of C2-ceramide or sphingomyelinase to intact cells. Furthermore,
TNF
alpha, sphingomyelinase, and C2-ceramide induce c-jun, a gene that is stimulated by the ATF-2 and c-Jun transcription factors. These data suggest that ceramide may act as a second messenger for a subset of
TNF
alpha's biochemical and biological effects.
...
PMID:Ceramide activates the stress-activated protein kinases. 755 90
Interleukin 1 (IL1) activated mitogen-activated protein (MAP) kinase kinase in human gingival and foreskin fibroblasts and KB cells. Maximal activity was found in cytosolic extracts made after stimulating cells for 15 min. On anion-exchange chromatography two differently charged forms of MAP kinase kinase were identified, both phosphorylated a kinase-defective mutant
MAP kinase
, and activated recombinant wild type
MAP kinase
to phosphorylate MBP. Both were inhibited by an antiserum to recombinant MAP kinase kinase and the less acidic form was identified on Western blotting as an antigen of approximately 43 kDa. Indistinguishable forms were very much more strongly induced by phorbol myristate acetate (PMA).
TNF
had a similar effect to that of IL1.
...
PMID:Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells. 769 14
The early growth response 1 (EGR-1) gene is induced by mitogenic and differentiating signals in diverse cell types. The present studies have examined the effects of TNF-alpha on the induction of EGR-1 expression in human myeloid leukemia cells and the potential cytoplasmic signaling cascades that transduce
TNF
-induced signals to the nucleus. The results demonstrate that treatment of HL-60 cells with
TNF
is associated with the transient induction of the EGR-1 gene. The results also demonstrate that
TNF
treatment is associated with activation of the serine/threonine kinase, pp90rsk, which acts upstream to EGR-1 gene induction. Partial purification of pp90rsk by affinity chromatography demonstrated an increase in S6 peptide phosphorylation in response to
TNF
treatment. Because
TNF
activates sphingomyelin hydrolysis, we also studied the effects of sphingomyelinase (SMase) on induction of EGR-1 and pp90rsk. The results demonstrate that SMase also activates pp90rsk and induces EGR-1 gene expression. Previous work has demonstrated that mitogen-activated protein (MAP) kinase activates pp90rsk. The present studies further show that treatment with
TNF
or SMase is associated with induction of both the
pp42
/44 MAP and the related Jun kinases. Induction of
pp42
/44
MAP kinase
activity is temporally related to activation of pp90rsk and the EGR-1 gene. These findings support the involvement of an
MAP kinase
/pp90rsk/EGR-1 cascade in the response of myeloid leukemia cells to
TNF
.
...
PMID:Activation of serine/threonine protein kinases and early growth response 1 gene expression by tumor necrosis factor in human myeloid leukemia cells. 770 52
Recombinant human TNF-alpha induces increased tyrosine phosphorylation of several proteins in human neutrophils (PMN) adhered to serum-coated plastic. When PMN are kept in suspension,
TNF
does not induce significant tyrosine phosphorylation. In adherent PMN, a 42-kDa protein (p42) displayed the most striking increase in tyrosine phosphorylation after
TNF
stimulation. Cell lysates of
TNF
-stimulated PMN were separated by two-dimensional gel electrophoresis and were immunoblotted with either anti-phosphotyrosine (alpha-PY) mAb or anti-
mitogen-activated protein kinase
(alpha-
MAPK
) mAb. Both Abs detected p42, and the spots were superimposable. Cell lysates were immunoprecipitated with agarose-conjugated alpha-PY mAb, electrophoresed, and then immunoblotted with alpha-
MAPK
Ab; alternatively, cell lysates were immunoprecipitated with agarose-conjugated alpha-
MAPK
Ab, electrophoresed, and then immunoblotted with alpha-PY mAb. In both cases, p42 was detected. These results demonstrate that p42 is a member of the
MAPK
family.
TNF
induces a time-and dose-dependent increase in tyrosine phosphorylation of p42 and
MAPK
activity. The degree of p42 tyrosine phosphorylation parallels the level of
MAPK
activity.
MAPK
activity was determined by measuring 32P phosphorylation of a synthetic peptide containing the recognition site on myelin basic protein for
MAPK
. PMN pretreatment with genistein, a tyrosine kinase inhibitor, inhibited the
TNF
-induced increase in tyrosine phosphorylation and
MAPK
activity. These results indicate that
TNF
signaling involves activation of
MAPK
.
...
PMID:TNF-alpha induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. 772 27
When applied to quiescent human aortic smooth muscle cells (AOSMC), endothelin-1 (ET-1) caused significant increases in
mitogen-activated protein kinase
(
MAPK
) activity, [3H]thymidine incorporation, and cell proliferation, confirming an activity of ET-1 as a potent mitogen on AOSMC. As an in vitro model to evaluate the significance of the mitogenic activity of ET-1 on smooth muscle cells during atherogenesis, we studied possible modulations of the responsiveness of the cells by treatment with various cytokines (IL-1 beta, IL-8,
TNF
alpha, and TGF beta). Of the four cytokines tested, we found that the treatment of the cells with IL-1 beta dramatically reduced the responsiveness of the cells to ET-1; IL-1 beta treatment at the concentration of 0.2 ng/ml for 8 h completely abolished the activity of ET-1 to induce the mitogenic responses. IL-1 beta treatment caused no changes in the responses induced by EGF, basic fibroblast growth factor, or PDGF. Studies on ET-1-induced intracellular signaling events in IL-1 beta-treated cells revealed that the failure of ET-1 to induce mitogenic responses was due to an increase in cAMP formation secondary to ET-1-induced activation of prostanoid metabolism. These findings on AOSMC in vitro raise the possibility that, under some inflammatory conditions in vivo, ETs may work as a negative modulator of smooth muscle cell proliferation.
...
PMID:Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. 776 93
Treatment of human diploid FS-4 fibroblasts with
TNF
or IL-1 led to a rapid increase in the phosphorylation of a approximately 28-kDa protein. Increased phosphorylation was seen after 5 min of
TNF
treatment, it reached a plateau between 10 and 30 min, and decreased thereafter. Immunoprecipitation with specific antibodies identified the 28-kDa protein as a member of the family of small heat shock proteins (Hsp28). Treatment of cells with different kinase inhibitors (staurosporine, H7, H8, HA-1004, or chelerythrine chloride) failed to inhibit
TNF
-induced Hsp28 phosphorylation, suggesting that neither protein kinase C nor other common protein kinases were involved. Treatment of FS-4 cells with sodium arsenite led to a very strong increase in the phosphorylation of Hsp28 demonstrable after 5 min and persisting for at least 4 h. Tyrosine phosphorylation of
pp42
and pp44 MAP kinases was increased by
TNF
treatment, whereas arsenite produced a modest increase in tyrosine phosphorylation of pp44 while decreasing that of
pp42
MAP kinase
. The finding that sodium arsenite strongly increased Hsp28 phosphorylation, together with the resistance of
TNF
-induced phosphorylation to kinase inhibitors, supports the notion that increased serine phosphorylation of Hsp28 in this system involves inhibition of protein phosphatase activity.
...
PMID:Pathways of heat shock protein 28 phosphorylation by TNF in human fibroblasts. 785 64
Tumor necrosis factor alpha (
TNF
alpha) is bound by two cell surface receptors, CD120a (p55) and CD120b (p75), that belong to the
TNF
/nerve growth factor receptor family and whose signaling is initiated by receptor multimerization in the plane of the plasma membrane. The initial signaling events activated by receptor crosslinking are unknown, although activation of the
mitogen-activated protein kinase
(
MAPK
) cascade occurs shortly after ligand binding to CD120a. In this study, we investigated the upstream kinases that mediate the activation of the 42-kDa
MAPK
p42mapk
/erk2 following crosslinking of CD120a in mouse macrophages. Exposure of mouse macrophages to
TNF
alpha stimulated a time-dependent increase in the activity of MAPK/ERK kinase (MEK) that temporally preceded peak activation of
p42mapk
/erk2. MEKs, dual-specificity threonine/tyrosine kinases, act as a convergence point for several signaling pathways including Ras/Raf, MEK kinase (MEKK), and Mos. Incubation of macrophages with
TNF
alpha was found to transiently stimulate a MEKK that peaked in activity within 30 sec of exposure and progressively declined toward basal levels by 5 min. By contrast, under these conditions, activation of either c-Raf-1 or Raf-B was not detected. These data suggest that the activation of the
MAPK
cascade in response to
TNF
alpha is mediated by the sequential activation of a MEKK and a MEK in a c-Raf-1- and Raf-B-independent fashion.
...
PMID:Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. 787 28
Tumor necrosis factor alpha (
TNF
alpha) has multiple biological functions including the prolonged activation of the collagenase and c-jun genes, which are regulated via their AP-1 binding sites. We show that incubating human fibroblasts with
TNF
alpha induces prolonged activation of
JNK
, the c-Jun kinase, which phosphorylates the transactivation domain of c-Jun. Furthermore, an immune complex kinase assay specifically demonstrates that
TNF
alpha stimulates the activity of JNK1, the recently described predominant form of
JNK
.
TNF
alpha also produces a small and transient increase in
extracellular signal-regulated kinase
(
ERK
) activity and no measured increase in Raf-1 kinase activity. On the other hand, epidermal growth factor causes a prolonged activation of Raf-1 kinase and
ERK
activity and a smaller, more transient activation of
JNK
, whereas the phorbol ester phorbol 12-myristate 13-acetate causes a small stimulation of Raf-1 kinase and a pronounced stimulation of
ERK
activity. The activation of
JNK
by
TNF
alpha does not correlate with Raf-1 or
ERK
activity. The kinetics of Raf-1,
ERK
, and
JNK
induction by epidermal growth factor, phorbol 12-myristate 13-acetate, or
TNF
alpha indicate distinct mechanisms of activation in human fibroblasts.
...
PMID:Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. 792 60
1
2
3
4
5
6
7
8
9
10
Next >>